- Home
- NPO vs MRUS Comparison
NPO vs MRUS Comparison
Compare NPO & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPO
- MRUS
- Stock Information
- Founded
- NPO 2002
- MRUS 2003
- Country
- NPO United States
- MRUS Netherlands
- Employees
- NPO N/A
- MRUS N/A
- Industry
- NPO Metal Fabrications
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- NPO Industrials
- MRUS Health Care
- Exchange
- NPO Nasdaq
- MRUS Nasdaq
- Market Cap
- NPO 4.9B
- MRUS 5.1B
- IPO Year
- NPO N/A
- MRUS 2016
- Fundamental
- Price
- NPO $209.88
- MRUS $95.98
- Analyst Decision
- NPO Buy
- MRUS Buy
- Analyst Count
- NPO 3
- MRUS 18
- Target Price
- NPO $243.33
- MRUS $93.72
- AVG Volume (30 Days)
- NPO 194.9K
- MRUS 1.4M
- Earning Date
- NPO 11-04-2025
- MRUS 10-31-2025
- Dividend Yield
- NPO 0.59%
- MRUS N/A
- EPS Growth
- NPO 58.40
- MRUS N/A
- EPS
- NPO 4.06
- MRUS N/A
- Revenue
- NPO $1,106,300,000.00
- MRUS $56,606,000.00
- Revenue This Year
- NPO $7.28
- MRUS $52.81
- Revenue Next Year
- NPO $5.60
- MRUS N/A
- P/E Ratio
- NPO $51.73
- MRUS N/A
- Revenue Growth
- NPO 6.44
- MRUS 57.54
- 52 Week Low
- NPO $133.50
- MRUS $33.19
- 52 Week High
- NPO $248.88
- MRUS $96.28
- Technical
- Relative Strength Index (RSI)
- NPO 38.61
- MRUS 80.10
- Support Level
- NPO $209.00
- MRUS $94.75
- Resistance Level
- NPO $223.27
- MRUS $95.10
- Average True Range (ATR)
- NPO 10.54
- MRUS 0.36
- MACD
- NPO -1.96
- MRUS -0.57
- Stochastic Oscillator
- NPO 5.46
- MRUS 82.89
About NPO Enpro Inc.
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.